TSE:LABS MediPharm Labs (LABS) Stock Price, News & Analysis C$0.08 -0.01 (-5.56%) As of 04/23/2025 03:17 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About MediPharm Labs Stock (TSE:LABS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MediPharm Labs alerts:Sign Up Key Stats Today's RangeC$0.09▼C$0.0950-Day RangeC$0.07▼C$0.1252-Week RangeC$0.06▼C$0.12Volume55,816 shsAverage Volume373,461 shsMarket CapitalizationC$35.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.Read More… Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address LABS Stock News HeadlinesMediPharm Labs Corp.April 1, 2025 | baystreet.caMediPharm Labs to Sell its Hope Facility to Rubicon Organics for $4.5MMarch 3, 2025 | finance.yahoo.comM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).April 24, 2025 | Paradigm Press (Ad)Medipharm Labs Terminates Facility Sale to Kensana HealthFebruary 10, 2025 | marketwatch.comMediPharm Labs terminates proposed sale of Napanee facility to Kensana HealthFebruary 10, 2025 | seekingalpha.comMediPharm Labs: Top 10 Undervalued Healthcare Sector Stocks on TSX (LABS)January 8, 2025 | theglobeandmail.comStockTalk | Cannabis Report: The Holiday EditionDecember 20, 2024 | msn.comXORTX Appoints Michael Bumby As CFO, Replacing James FairbairnDecember 19, 2024 | markets.businessinsider.comSee More Headlines LABS Stock Analysis - Frequently Asked Questions How have LABS shares performed this year? MediPharm Labs' stock was trading at C$0.06 at the beginning of 2025. Since then, LABS shares have increased by 41.7% and is now trading at C$0.09. View the best growth stocks for 2025 here. How do I buy shares of MediPharm Labs? Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of MediPharm Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), MediPharm Labs (MEDIF), BlackBerry (BB), HEXO (HEXO), Lightspeed Commerce (LSPD) and Organigram (OGI). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:LABS CIKN/A Webwww.medipharmlabs.com Phone705 719 7425FaxN/AEmployees130Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-12,047,047.14 Net Margins-30.56% Pretax MarginN/A Return on Equity-24.41% Return on Assets-7.17% Debt Debt-to-Equity Ratio1.45 Current Ratio3.21 Quick Ratio3.10 Sales & Book Value Annual SalesC$39.42 million Price / Sales0.89 Cash FlowC$0.07 per share Price / Cash Flow1.30 Book ValueC$0.11 per share Price / Book0.78Miscellaneous Outstanding Shares414,999,000Free FloatN/AMarket CapC$35.27 million OptionableNot Optionable Beta0.88 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (TSE:LABS) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.